Matrix Metalloproteinases as Valid Clinical Target

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|3|333-346

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.3, 2007-01, pp. : 333-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Matrix Metalloproteinases: A Therapeutic Target in Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 9, Iss. 13, 2003-05 ,pp. : 1033-1040

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinases

By  

Current Medicinal Chemistry, Vol. 17, Iss. 31, 2010-11 ,pp. : 3751-3768

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinases in Coronary Artery Disease:Clinical and Therapeutic Implications and Pathological Significance

By  

Current Medicinal Chemistry, Vol. 12, Iss. 8, 2005-04 ,pp. : 917-925

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinases in Respiratory Diseases: From Pathogenesis to Potential Clinical Implications

By  

Current Medicinal Chemistry, Vol. 16, Iss. 10, 2009-04 ,pp. : 1214-1228

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease

By  

Current Pharmaceutical Design, Vol. 13, Iss. 17, 2007-06 ,pp. : 1787-1802

Bentham Science Publishers

Access to resources Recommend Favorite